
Moderna’s influenza vaccine mFlusiva has actually been authorized for usage in grownups ages 50 and older.
(Image credit: Catherine Falls Commercial by means of Getty Images)
The U.S. Food and Drug Administration (FDA) has actually authorized a brand-new seasonal influenza vaccine that utilizes mRNA as its base.
Moderna, the vaccine’s maker, revealed Wednesday (Aug. 5) that a vaccine advisory committee to the FDA all concurred that the shot is safe and reliable for avoiding health problem from seasonal influenza. The shot, called mFlusiva or mRNA-1010, has actually been authorized for individuals ages 50 and older.
Most current Videos FromLive Science
Register for the Live Science everyday newsletter now
Get the world’s most interesting discoveries provided directly to your inbox.
Nicoletta Lanese is the health channel editor at Live Science and was formerly a news editor and personnel author at the website. She is a recipient of the 2026 AHCJ International Health Study Fellowship, with a job concentrated on antibiotic stewardship practices in Japan and the U.S. They hold a graduate certificate in science interaction from UC Santa Cruz and degrees in neuroscience and dance from the University of Florida. Beyond Live Science, Lanese’s work has actually appeared in The Scientist, Science News, the Mercury News, Mongabay and Stanford Medicine Magazine, to name a few outlets. Based in NYC, she likewise stays involved in dance and carries out in regional choreographers’ work.
You need to verify your show and tell name before commenting
Please logout and after that login once again, you will then be triggered to enter your screen name.
Find out more
As an Amazon Associate I earn from qualifying purchases.







